12:00 AM
 | 
Sep 05, 2000
 |  BC Week In Review  |  Company News  |  Deals

NPS, Forest Laboratories deal

NPSP's NPS Allelix Corp. subsidiary (Toronto, Ontario) granted FRX exclusive worldwide development and marketing rights to its ALX-0646 selective serotonin agonist to...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >